skip navigation links
National Cancer Institute
EVS Logo NCI Term Browser Enterprise Vocabulary Services
Terminologies Value Sets Mappings
Version: 17.06d (Release date: 2017-06-26)
SearchBox Top
SearchBox Bottom
Biomed 101 (Code C2206)

Terms & Properties Synonym Details Relationships Mapping View All  
Terms & Properties

Preferred Name: Biomed 101

Definition: An agent binding to the leukotriene B4 receptor, leading to reduced interleukin-2 mediated hypoxia. Biomed 101 does not affect interleukin-2 antitumor activity. (NCI04)

NCI-GLOSS Definition: A substance that is being studied for its ability to decrease the side effects of interleukin-2 (IL-2).

Label: Biomed 101

NCI Thesaurus Code: C2206 (Search for linked caDSR metadata)  (search value sets)

NCI Metathesaurus Link: C0879447  (see NCI Metathesaurus info)

Synonyms & Abbreviations: (see Synonym Details)
Biomed 101

External Source Codes: 
PDQ Closed Trial Search ID 37882
PDQ Open Trial Search ID 37882 (check for NCI PDQ open clinical trial info)
UMLS CUI C0879447

Other Properties:
     Name Value (qualifiers indented underneath)
code C2206
Legacy_Concept_Name Biomed_101
Semantic_Type Pharmacologic Substance

Additional Concept Data: 
Defined Fully by Roles: No  

URL: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C2206

Mainbox Bottom